The Dental Drug Delivery System for Prevention of Dental Caries
- 397 Downloads
A new therapy for the management of early caries lesions and caries prevention was established for clinical use. This therapy was named the Dental Drug Delivery System (3DS), and its effectiveness was confirmed by clinical evaluations. The 3DS method involves the application of either antimicrobial drugs or fluoride gels, with individual trays at the chair-side and also for home care program. By using the individual trays, only the cariogenic bacteria “Streptococcus mutans” that adheres to the tooth surface is controlled without changing the core composition of oral microflora. Therefore, we recommend the use of this method in dental clinics for caries management. The 3DS method should be used especially by pregnant women and mothers raising small children because children most often receive the S. mutans from their mothers via saliva. Patients with dental implants also should be treated by 3DS in order to prevent peri-implantitis. Perioperative patients and bed-ridden people who find it physically challenging to take care of their teeth would also benefit from the 3DS. Patients with severe halitosis are also candidates for 3DS treatment. The scientific rationale of 3DS and the clinical procedure involved are introduced in this article.
KeywordsDental caries Caries assessment Dental Drug Delivery System 3DS Streptococcus mutans
This work was supported by JSPS KAKENHI Grant Number 15K15777.
Compliance with Ethical Standards
Conflict of Interest
Nobuhiro Hanada reports grants from the Japanese government during the conduct of study.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Newbrun E. Cariology. Boltimore: The Williams & Wilkins Company; 1978. p. 259.Google Scholar
- 2.Murata T, Hanada N (submitted) Contribution of chloride channel permease to fluoride resistance in Streptococcus mutans Google Scholar
- 5.Takeuchi H, Fukushima K, Senpuku H, Nomura Y, Kaneko N, Yano A, et al. Clinical study of mutans streptococci using 3DS and monoclonal antibodies. Jpn J Infect Dis. 2000;54:34–6.Google Scholar
- 10.•Katsumura S, Nomura Y, Nishikawara F, Nishikawa T, Kumagai T, Sato K, et al. Pilot study of the effect of a new dental drug delivery system for removal of mutans streptococci infection in adults. Asian Pac J Dent. 2013;13:11–8. Randomized controlled trials (RCT) are known as the best method to prove causality. This paper is the first report on RCT of 3DS method.Google Scholar
- 21.Sandham HJ, Brown J, Chan KH, Phillips HI, Burgess RC, Stokl AJ. Clinical trial in adults of an antimicrobial varnish for study. Scand J Dent Res. 1994;102:109–12.Google Scholar
- 22.•Baker JL, Sudarsan N, Weinberg Z, et al. Widespread genetic switches and toxicity resistance proteins for fluoride. Science. 2012;335:233–5. Fluoride resistance of S. mutans hypothesized that fluoride riboswitch or another type of fluoride sensor system can exclude the fluoride ion from the cell membrane, thereby developing resistance. This paper is the first report on an existence of fluoride riboswitch. Google Scholar
- 23.Mariotti A, Hefti F. Drug for the control of supragingival plaque. In: Craig CR, Stitzel RE, editors. Modern pharmacology with clinical applications. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 504.Google Scholar
- 24.•Kumar PS, Mason MR, Brooker MR, O’Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol. 2012;39:425–33. Peri-implantitis biofilms were associated with higher level of Streptococcus mutans than healthy teeth and healthy implant biofilms. Biofilms with higher level of Streptococcus mutans could be changed by 3DS method. Google Scholar